Literature DB >> 3368012

Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat.

E Hétier1, A Boireau, P Dubédat, J C Blanchard.   

Abstract

The effects of neurotensin (NT) on the K+-evoked release of endogenous and tritiated dopamine in striatum and on 3H-dopamine in slices from nucleus accumbens and prefrontal cortex were investigated. In striatum, NT (1-1,000 nM) elicited a dose-dependent increase in endogenous and 3H-dopamine release. The dose-response curves were comparable with the two methods. Concerning the comparison of NT modulation of 3H-dopamine release in the three cerebral structures, the peptide induced a more marked effect in striatum with a maximal effect of 150% increase. In accumbens, NT (1-1,000 nM) potentiated the K+-evoked 3H-dopamine release, but in contrast with striatum, the plateau corresponded to a 50% increase. In prefrontal cortex, NT (1-1,000 nM) induced small but significant effects, with a maximal increase of 50% at 100 nM. Acetyl-NT (8-13) displayed an action similar to the natural peptide while NT (1-8) did not exhibit any effect, suggesting that the action of NT involved a receptor. The presence of tetrodotoxin did not alter the facilitating effects of NT in the three structures, indicating that interneurons were not involved in the action of NT. The comparison of the effects of NT showed that in terms of efficacy, NT induced an increase in dopamine release more marked in striatum than in nucleus accumbens and prefrontal cortex. These results are consistent with differences in NT receptors localization in these three dopaminergic structures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368012     DOI: 10.1007/bf00169470

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.

Authors:  D Herve; J P Tassin; J M Studler; C Dana; P Kitabgi; J P Vincent; J Glowinski; W Rostene
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

3.  Binding of [3H]neurotensin in human brain: properties and distribution.

Authors:  K S Kanba; S Kanba; H Okazaki; E Richelson
Journal:  J Neurochem       Date:  1986-03       Impact factor: 5.372

4.  Neurotensin facilitates dopamine release in vitro from rat striatal slices.

Authors:  M E de Quidt; P C Emson
Journal:  Brain Res       Date:  1983-09-12       Impact factor: 3.252

5.  Neurotensin receptors are located on dopamine-containing neurones in rat midbrain.

Authors:  J M Palacios; M J Kuhar
Journal:  Nature       Date:  1981-12-10       Impact factor: 49.962

Review 6.  Distribution of neurotensin and its receptor in the central nervous system.

Authors:  G R Uhl
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  Autoradiographic distribution of [3H]neurotensin receptors in rat brain: visualization by tritium-sensitive film.

Authors:  R Quirion; P Gaudreau; S St-Pierre; F Rioux; C B Pert
Journal:  Peptides       Date:  1982 Sep-Oct       Impact factor: 3.750

8.  Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices.

Authors:  Y Okuma; Y Fukuda; Y Osumi
Journal:  Eur J Pharmacol       Date:  1983-09-16       Impact factor: 4.432

9.  Comparison between radiolabelled and endogenous dopamine release from rat striatal slices: effects of electrical field stimulation and regulation by D2-autoreceptors.

Authors:  H Herdon; S R Nahorski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

10.  Neurotensin effect on dopamine release and calcium transport in rat striatum: interactions with diphenylalkylamine calcium antagonists.

Authors:  F Battaini; S Govoni; S Di Giovine; M Trabucchi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

View more
  8 in total

1.  Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling.

Authors:  Henry H Yin; Louise Adermark; David M Lovinger
Journal:  Neuropharmacology       Date:  2007-06-22       Impact factor: 5.250

Review 2.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

3.  Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex.

Authors:  R Fernández; R Sabater; J A Sáez; R Montes; F Alba; J M Ferrer
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 4.  Direct dopamine terminal regulation by local striatal microcircuitry.

Authors:  Suzanne O Nolan; Jennifer E Zachry; Amy R Johnson; Lillian J Brady; Cody A Siciliano; Erin S Calipari
Journal:  J Neurochem       Date:  2020-06-19       Impact factor: 5.372

5.  Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.

Authors:  F H Marshall; S Barnes; R D Pinnock; J Hughes
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

6.  Role of calcium in neurotensin-evoked enhancement in firing in mesencephalic dopamine neurons.

Authors:  Fannie St-Gelais; Mark Legault; Marie-Josée Bourque; Pierre-Paul Rompré; Louis-Eric Trudeau
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

7.  Neurotensin receptor 1 gene (NTSR1) polymorphism is associated with working memory.

Authors:  Jin Li; Chuansheng Chen; Chunhui Chen; Qinghua He; He Li; Jun Li; Robert K Moyzis; Gui Xue; Qi Dong
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

8.  Neurotensin Induces Presynaptic Depression of D2 Dopamine Autoreceptor-Mediated Neurotransmission in Midbrain Dopaminergic Neurons.

Authors:  Elisabeth Piccart; Nicholas A Courtney; Sarah Y Branch; Christopher P Ford; Michael J Beckstead
Journal:  J Neurosci       Date:  2015-08-05       Impact factor: 6.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.